Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -8.015% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CC(C)c1ccc(NC2CCCN(C(=O)c3ccccc3-c3ncc[nH]3)C2)cc1
b: Cc1ccc(Cn2nnc3c(=O)n(Cc4ccccc4C)cnc32)cc1
Answer: a. CC(C)c1ccc(NC2CCCN(C(=O)c3ccccc3-c3ncc[nH]3)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(NC2CCCN(C(=O)c3ccccc3-c3ncc[nH]3)C2)cc1
CC(C)c1ccc(NC2CCCN(C(=O)c3ccccc3-c3ncc[nH]3)C2)cc1
[2-(1H-imidazol-2-yl)phenyl]-[3-(4-propan-2-ylanilino)piperidin-1-yl]methanone